Jakob Benedict Seidelin
Clinical Professor
Department of Clinical Medicine
Borgmester Ib Juuls Vej 1, 2730 Herlev
Herlev Ringvej 75, Building: Gastroenheden, Laboratorium 54O3, Herlev Hospital
2730 Herlev
Denmark
Member of:
Internal Medicine: Gastroenterology and Hepatology
- 2022
- Published
Early intestinal ultrasound predicts intravenous corticosteroid response in hospitalized patients with severe ulcerative colitis
Ilvemark, J. F. K. F., Wilkens, R., Thielsen, P., Dige, A., Boysen, T., Brynskov, J., Bjerrum, Jakob Tveiten & Seidelin, Jakob Benedict, 2022, In: Journal of Crohn's & colitis. 16, 11, p. 1725–1734Research output: Contribution to journal › Journal article › Research › peer-review
- Published
The effect of induced hyperammonaemia on sleep and melanopsin-mediated pupillary light response in patients with liver cirrhosis: A single-blinded randomized crossover trial
Kann, A. E., Ba-Ali, S., Seidelin, Jakob Benedict, Larsen, F. S., Hamann, Steffen & Bjerring, Peter Nissen, 2022, In: PLoS ONE. 17, 9 , e0275067.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Prediction of Relapse After Anti–Tumor Necrosis Factor Cessation in Crohn's Disease: Individual Participant Data Meta-analysis of 1317 Patients From 14 Studies
Pauwels, R. W. M., van der Woude, C. J., Nieboer, D., Steyerberg, E. W., Casanova, M. J., Gisbert, J. P., Kennedy, N. A., Lees, C. W., Louis, E., Molnár, T., Szántó, K., Leo, E., Bots, S., Downey, R., Lukas, M., Lin, W. C., Amiot, A., Lu, C., Roblin, X., Farkas, K. & 15 others, , 2022, In: Clinical Gastroenterology and Hepatology. 20, 8, p. 1671-1686.e16Research output: Contribution to journal › Review › Research › peer-review
- Published
Etrolizumab as induction and maintenance therapy for ulcerative colitis in patients previously treated with tumour necrosis factor inhibitors (HICKORY): a phase 3, randomised, controlled trial
Peyrin-Biroulet, L., Hart, A., Bossuyt, P., Long, M., Allez, M., Juillerat, P., Armuzzi, A., Loftus, E. V., Ostad-Saffari, E., Scalori, A., Oh, Y. S., Tole, S., Chai, A., Pulley, J., Lacey, S., Sandborn, W. J., Aguilar, H., Ahmad, T., Akriviadis, E., Aldeguer Mante, X. & 31 others, , 2022, In: The Lancet Gastroenterology and Hepatology. 7, 2, p. 128-140 13 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Etrolizumab for maintenance therapy in patients with moderately to severely active ulcerative colitis (LAUREL): a randomised, placebo-controlled, double-blind, phase 3 study
Vermeire, S. & LAUREL Study Group, L. S. G., 2022, In: The Lancet Gastroenterology and Hepatology. 7, 1, p. 28-37 10 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Praktisk anvendelse af thiopuriner hos patienter med kronisk inflammatoriske tarmsygdomme
Zhao, M., Wewer, M. D., Bjerrum, Jakob Tveiten , Steenholdt, Casper, Schiødt, Frank Vinholt, Haderslev, K., Kiszka-Kanowitz, M., Munkholm, Pia, Seidelin, Jakob Benedict & Burisch, J., 2022, In: Ugeskrift for Laeger. 184, 11, V09210706.Research output: Contribution to journal › Review › Research › peer-review
ID: 33971112
Most downloads
-
1908
downloads
Identification of TNF-α-responsive promoters and enhancers in the intestinal epithelial cell model Caco-2
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
246
downloads
Characterization of the enhancer and promoter landscape of inflammatory bowel disease from human colon biopsies
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
196
downloads
Culturing human intestinal stem cells for regenerative applications in the treatment of inflammatory bowel disease
Research output: Contribution to journal › Review › Research › peer-review
Published